Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities

Bioorg Med Chem Lett. 2010 Oct 15;20(20):6088-92. doi: 10.1016/j.bmcl.2010.08.047. Epub 2010 Aug 20.

Abstract

A new series of thiazole-substituted 1,1,1,3,3,3-hexafluoro-2-propanols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Key analogs caused dose-dependent decreases in food intake and body weight in obese mice. Acute treatment with these compounds also led to a drop in elevated blood glucose in a murine model of type II diabetes.

MeSH terms

  • Animals
  • Anti-Obesity Agents / chemical synthesis
  • Anti-Obesity Agents / chemistry
  • Anti-Obesity Agents / pharmacology
  • Anti-Obesity Agents / therapeutic use*
  • Blood Glucose / drug effects
  • Body Weight / drug effects
  • Carboxy-Lyases / antagonists & inhibitors*
  • Carboxy-Lyases / metabolism
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Design*
  • Eating / drug effects
  • Humans
  • Hypoglycemic Agents / chemical synthesis
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Mice
  • Mice, Inbred C57BL
  • Obesity / drug therapy*
  • Propanols / chemical synthesis
  • Propanols / chemistry
  • Propanols / pharmacology
  • Propanols / therapeutic use*
  • Thiazoles / chemical synthesis
  • Thiazoles / chemistry
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use

Substances

  • Anti-Obesity Agents
  • Blood Glucose
  • Hypoglycemic Agents
  • Propanols
  • Thiazoles
  • hexafluoroisopropanol
  • Carboxy-Lyases
  • malonyl-CoA decarboxylase